An observational study in Meningitis, Meningococcal and Sequela, sponsored by Centre Hospitalier Intercommunal Creteil. Terminated at 9 sites in France. Open to participants aged Up to 17 Years. Per ClinicalTrials.gov, last updated 2025-06-13.
Sponsored by Centre Hospitalier Intercommunal Creteil · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
While the initial evolution of meningococcal meningitis (MM) is well described, there are few data on the long-term evolution, beyond 1 year.
The objective of this research is to evaluate the sequelae of MM beyond 1 year in patients with a history of MM followed in Paris area, France. Most children with MM in France have been included in the MM register and are still being followed. Parents will be offered a detailed clinical evaluation of their child including: a clinical and neurological examination, a cognitive performance assessment, an auditory, speech and visual assessment and an evaluation of the child's progress at school.
125 studies on the registry are indexed under Meningitis, Meningococcal; 10 are open to participants now.
This study's enrollment of 43 is below the median of 180 across 11 observational studies indexed under Meningitis, Meningococcal.
Browse Meningitis, Meningococcal studies →Centre Hospitalier Intercommunal Creteil is the lead sponsor of 132 studies on the registry; 37 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Children from 0 to 17 years old who had meningococcal meningitis between 2010 and 2019
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
clinical and neurological examination, psychological evaluation (cognitive performance), an auditory, speech and visual assessment and an evaluation of the child's school performance
Number of children with at least one neurological, orthopedic or sensory sequelae
Time frame: 1 year
Number of children with severe neurological sequelae
Time frame: 1 year
Number of children with orthopedic complications
Time frame: 1 year
Number of children with sensory disorders
Time frame: 1 year
Number of children with skin sequelae
Time frame: 1 year
Number of children with learning disabilities
Time frame: 1 year
Number of children with cognitive or psychological difficulties identified on the WPPSI, WISC V or VINELAND depending on their age and capacity
95% of the population has a Total IQ between 70 and 130 (from low intelligence to high intelligence).
Time frame: 1 year
Number of consultations during follow-up
Time frame: 1 year
Post-traumatic stress in parents using the IES-R questionnaire
A score up to 33 is associated with a stress post traumatic
Time frame: 1 year
Plan to share: No
Ran from Jul 2021 to primary completion in May 2025, 46 months.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Intercommunal Creteil →